Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Parents want more warnings after a brain-eating amoeba killed their son on a South Carolina lake
Recommended
A painful trade: Swapping wine for THC landed her in the ER and sick for months
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by RevolKa Ltd.
RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)
June 30, 2025
From
RevolKa Ltd.
Via
Business Wire
RevolKa Ltd. Secures 210 million JPY (US$1.4 million) Series A Extension Funding to Advance Therapeutic Programs
May 19, 2025
From
RevolKa Ltd.
Via
Business Wire
RevolKa Ltd. Announces the Closing of a 250 Million JPY (US$1.7 Million) Series A Extension Funding to Accelerate Drug-Discovery Programs
August 29, 2024
From
RevolKa Ltd.
Via
Business Wire
RevolKa Signed Master Service Agreement with Daiichi Sankyo
May 27, 2024
From
RevolKa Ltd.
Via
Business Wire
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
April 18, 2024
From
RevolKa Ltd.
Via
Business Wire
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
January 23, 2024
From
RevolKa Ltd.
Via
Business Wire
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
June 23, 2023
From
RevolKa Ltd.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.